Medical News

RSS

New minimally invasive procedure to treat ruptured brain aneurysm developed

Researchers in Finland have identified an effective new treatment option for patients who have suffered a ruptured brain aneurysm, a potentially life-threatening event. Results of the new study on stent-assisted coil embolization were published today in the online edition of Radiology.

25 Aug 2009

Myoderm expands its portfolio to include drug procurement, management and distribution services

Myoderm, a leading global pharmaceutical supplier of comparator drugs for clinical research and clinical trials, has expanded its portfolio to include Distribution Management Services. This new capability provides their clients with an efficient solution for sourcing, managing, and distributing off-the-shelf, commercial drugs used in clinical trials.

25 Aug 2009

Neurogen stockholders to receive $11 million in Ligand Pharmaceuticals common stock as part of acquisition deal

Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) and Neurogen Corporation (NASDAQ:NRGN) announced today they have entered into a definitive merger agreement under which Ligand will acquire Neurogen. Under the transaction, Neurogen stockholders will receive an estimated $11 million in Ligand common stock and will be granted Contingent Value Rights (“CVRs”) under four CVR agreements.

25 Aug 2009

Insurers seek savings by offering coverage for care in other countries

More insurers are offering networks of doctors overseas and in other countries for their policyholders as a way to save money as lawmakers struggle with how to drive down costs, The Associated Press/USA Today reports.

25 Aug 2009

UCB and sanofi-aventis U.S. receive FDA's approval for XYZAL to treat allergies in children

UCB and sanofi-aventis U.S. announced today that the U.S. Food and Drug Administration (FDA) has approved XYZAL(R) (levocetirizine dihydrochloride) for children age six months and older for the relief of symptoms of perennial allergic rhinitis (indoor allergies) and chronic idiopathic urticaria (chronic hives) and for children age two years and older for symptoms of seasonal allergic rhinitis (outdoor allergies).

25 Aug 2009

Insurance industry may benefit from reform, employees attend town halls to counter criticism

Lashed by liberals and threatened with more government regulation, the insurance industry nevertheless rallied its lobbying and grass-roots resources so successfully in the early stages of the healthcare overhaul deliberations that it is poised to reap a financial windfall," The Los Angeles Times reports.

25 Aug 2009

Milestone Scientific receives Notice of Allowance to use disposable hand piece for fluid administration

Milestone Scientific Inc. (OTC Bulletin Board: MLSS), the recognized leader in advanced injection technologies, today announced that the United States Patent and Trademark Office has issued a Notice of Allowance for Milestone's U.S. patent application directed to the use of its disposable hand piece for fluid administration.

25 Aug 2009

FDA issues marketing approval for APP Pharmaceuticals' Penicillin G potassium for Injection, USP

APP Pharmaceuticals, Inc., a wholly owned subsidiary of Fresenius Kabi Pharmaceuticals Holding, Inc. (NASDAQ: APCVZ), announced today that it has received approval from the U.S. Food and Drug Administration (FDA) to market penicillin G potassium for Injection, USP, in two dosage strengths. Penicillin G is therapeutically equivalent to the reference drug PfizerPen™ G, which is marketed by the innovator Pfizer, Inc.

25 Aug 2009

Ecology Coatings collaborates with a tobacco company for producing fire standard compliant cigarettes

Ecology Coatings, Inc., a leader in the discovery and development of nanotechnology-enabled, ultraviolet-curable advanced coatings, today announced that it has signed a collaboration agreement with a major tobacco company for the application of its technology for producing "fire standard compliant" (FSC) cigarettes.

25 Aug 2009

NIAID funds Nanotherapeutic for developing an inhaled version of the injectable antiviral drug

Nanotherapeutics, Inc., today announced that it has been awarded a $30.9 Million, 5-year contract from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to develop an inhaled version of the injectable antiviral drug, cidofovir, for non-invasive, post-exposure prophylaxis and treatment of the Category A bioterrorism agent smallpox (Variola major).

25 Aug 2009

Study suggests that artificially sweetened beverages may help to control weight

A new study published in the International Journal of Obesity reports that consumption of sugar-free beverages sweetened with low-calorie sweeteners increases dietary restraint, a key aspect of successful weight maintenance.

25 Aug 2009

Rising costs and patient loads push some primary care MDs to concierge practices

Some primary care doctors are changing their practices, The Philadelphia Inquirer reports: "Faced with rising costs and patient loads, a small but growing number of primary-care doctors are sharply reducing their practice sizes and charging each patient annual fees of about $2,000 in exchange for personalized care.

25 Aug 2009

FDA approves new model of ZOLL's LifeVest wearable defibrillator

ZOLL Medical Corporation (Nasdaq GS: ZOLL), a manufacturer of resuscitation devices and related software solutions, has received approval from the U.S. Food and Drug Administration (FDA) to market and sell a new model of the LifeVest® wearable defibrillator.

25 Aug 2009

Low-carbohydrate and high-protein diet increases the risk for atherosclerosis and impaired blood vessels

Even as low-carbohydrate/high-protein diets have proven successful at helping individuals rapidly lose weight, little is known about the diets' long-term effects on vascular health.

25 Aug 2009

Report assessing school-based policies that address the health of students released by AAFA

For over 8 million children with asthma, food allergies and related conditions, the school-house is a focal point for managing their diseases. Now for the second year in a row, the Asthma and Allergy Foundation of America (AAFA) has released a report assessing school-based policies that address student health for elementary, middle and high schools in all 50 states.

25 Aug 2009

New technique developed to identify gene copy number variations

A research team led by Associate Professor Jonathan Sebat, Ph.D., of Cold Spring Harbor Laboratory (CSHL) has developed a sensitive and accurate way of identifying gene copy number variations (CNVs).

25 Aug 2009

Comparative effectiveness: Back surgery remains popular despite poor study results

Studies have recently found that vertebroplasty - a type of back surgery in which cement is injected into the spine - isn't effective, but many patients and their doctors insist it works.

25 Aug 2009

Survey reveals that many Americans believe controversial statements about health care reform

Findings from a national survey of Americans by researchers from Indiana University Center for Health Policy and Professionalism Research (CHPPR) and the Indiana University Center for Bioethics says that Americans do believe the "myths" about health care reform, confirming that the White House may indeed be losing this battle.

25 Aug 2009

Studies reveal that obese men are at increased risk for erectile dysfunction

Obese men are at increased risk for erectile dysfunction (ED), likely caused by atherosclerosis-related hypertension and cardiovascular disease, as well as hormonal changes associated with obesity, as described in a timely article published in Obesity and Weight Management, a journalzine published by Mary Ann Liebert, Inc.

25 Aug 2009

Avacor teams up with HopeCuts and Team Continuum to provide help for cancer patients

Avacor(R )Products LLC (http://www.avacor.com), a leading product line in the hair re-growth industry, has recently teamed up with two charitable organizations, HopeCuts, a division of City of Hope (http://www.cityofhope.org), and Team Continuum (http://www.teamcontinuum.net). Avacor((R)) is teaming up with both charities in an effort to help those fighting cancer as well as to help find new ways to fight this prolific disease.

25 Aug 2009

Medical News

New minimally invasive procedure to treat ruptured brain aneurysm developed

Myoderm expands its portfolio to include drug procurement, management and distribution services

Neurogen stockholders to receive $11 million in Ligand Pharmaceuticals common stock as part of acquisition deal

Insurers seek savings by offering coverage for care in other countries

UCB and sanofi-aventis U.S. receive FDA's approval for XYZAL to treat allergies in children

Insurance industry may benefit from reform, employees attend town halls to counter criticism

Milestone Scientific receives Notice of Allowance to use disposable hand piece for fluid administration

FDA issues marketing approval for APP Pharmaceuticals' Penicillin G potassium for Injection, USP

Ecology Coatings collaborates with a tobacco company for producing fire standard compliant cigarettes

NIAID funds Nanotherapeutic for developing an inhaled version of the injectable antiviral drug

Study suggests that artificially sweetened beverages may help to control weight

Rising costs and patient loads push some primary care MDs to concierge practices

FDA approves new model of ZOLL's LifeVest wearable defibrillator

Low-carbohydrate and high-protein diet increases the risk for atherosclerosis and impaired blood vessels

Report assessing school-based policies that address the health of students released by AAFA

New technique developed to identify gene copy number variations

Comparative effectiveness: Back surgery remains popular despite poor study results

Survey reveals that many Americans believe controversial statements about health care reform

Studies reveal that obese men are at increased risk for erectile dysfunction

Avacor teams up with HopeCuts and Team Continuum to provide help for cancer patients

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Latest News